Malin Flodström Tullberg

Om mig
Publikationer
CV
Populärvetenskap och samverkan

Om mig

Malin Flodström Tullberg är professor i typ 1-diabetes vid institutionen för medicin, Huddinge, och forskar kring type 1 diabetes.

Forskningsbeskrivning

Professor Malin Flodström Tullbergs forskning syftar till att förstå hur sjukdomen typ-1 diabetes uppstår med målsättningen att utveckla sjukdomspreventiva botande behandlingar.

Artiklar

Article: DIABETOLOGIA. 2025;68(10):2277-2289
Frequent longitudinal blood microsampling and proteome monitoring identify disease markers and enable timely intervention in a mouse model of type 1 diabetes
Parajuli A; Bendes A; Byvald F; Stone VM; Ringqvist EE; Butrym M; Angelis E; Kipper S; Bauer S; Roxhed N; Schwenk JM; Flodstrom-Tullberg M
Journal article: JOURNAL OF BIOMEDICAL SCIENCE. 2025;32(1):86
Coxsackie B1 virus-like particle vaccine modified to exclude a highly conserved immunoreactive region from the capsid induces potent neutralizing antibodies and protects against infection in mice
Soppela S; Gonzalez-Rodriguez M; Stone VM; Mustonen I; Jouppila NVV; Lampinen V; Haikarainen T; Flodstrom-Tullberg M; Junttila IS; Hankaniemi MM
Article: SCIENCE IMMUNOLOGY. 2025;10(109):eadq4881
Tissue origin and virus specificity shape human CD8⁺ T cell cytotoxicity
Niessl J; Mueller TR; Constantz C; Cai C; Nilsen V; Ballesteros OR; Adamo S; Kammann T; Mouchtaridi E; Gao Y; Akhirunnesa M; Raineri EJM; Weigel W; Kokkinou E; Stamper C; Marchalot A; Bassett J; Ferreira S; Rodahl I; Wild N; Stellaccio T; Brownlie D; Ringqvist E; Flodstrom-Tullberg M; Llewellyn-Lacey S; Tibbitt C; Hammer Q; Michaelsson J; Price DA; Mjosberg J; Marquardt N; Sandberg JK; Sekine T; Jorns C; Buggert M
Article: GENES AND IMMUNITY. 2025;26(1):70-74
The HLA-B-21 M/T dimorphism associates with disease severity in COVID-19
Strunz B; Momayyezi P; Bilev E; Muvva JR; Chen P; Bister J; Schaffer M; Akber M; Cornillet M; Horowitz A; Malmberg K-J; Rooyackers O; Aleman S; Ljunggren H-G; Bjorkstrom NK; Stralin K; Hammer Q
Article: METHODS. 2024;231:94-102
Production, analysis, and safety assessment of a soil and plant-based natural material with microbiome- and immune-modulatory effects
Parajuli A; Makela I; Roslund MI; Ringqvist E; Manninen J; Sun Y; Nurminen N; Oikarinen S; Laitinen OH; Hyoty H; Flodstrom-Tullberg M; Sinkkonen A
Article: ANTIVIRAL RESEARCH. 2024;231:106021
Vemurafenib inhibits the replication of diabetogenic enteroviruses in intestinal epithelial and pancreatic beta cells
Butrym M; Byvald F; Blanter M; Ringqvist EE; Vasylovska S; Marjomaki V; Lau J; Stone VM; Flodstrom-Tullberg M
Article: JOURNAL OF INFECTIOUS DISEASES. 2024;230(2):e318-e326
Type I Interferon Autoantibodies Correlate With Cellular Immune Alterations in Severe COVID-19
Strunz B; Maucourant C; Mehta A; Wan H; Du L; Sun D; Chen P; Nordlander A; Gao Y; Cornillet M; Bister J; Kvedaraite E; Christ W; Klingstrom J; Geanon D; Parke A; Ekwall-Larson A; Rivino L; MacAry PA; Aleman S; Buggert M; Ljunggren H-G; Pan-Hammarstrom Q; Lund-Johansen F; Stralin K; Bjorkstrom NK
Journal article: IMMUNE SYSTEM. 2024;1(1):1-13
Differential Effect of JAK1/2 and TYK2 Inhibitors on Type III Interferon Induced Antiviral Defence in Human Intestinal Epithelial Cells
Castro MA; Ringqvist EE; Parajuli A; Stone VM; Flodström-Tullberg M
Article: SCIENCE ADVANCES. 2024;10(10):eadl1122
Coxsackievirus infection induces direct pancreatic β cell killing but poor antiviral CD8⁺ T cell responses
Vecchio F; Carre A; Korenkov D; Zhou Z; Apaolaza P; Tuomela S; Burgos-Morales O; Snowhite I; Perez-Hernandez J; Brandao B; Afonso G; Halliez C; Kaddis J; Kent SC; Nakayama M; Richardson SJ; Vinh J; Verdier Y; Laiho J; Scharfmann R; Solimena M; Marinicova Z; Bismuth E; Lucidarme N; Sanchez J; Bustamante C; Gomez P; Buus S; You S; Pugliese A; Hyoty H; Rodriguez-Calvo T; Flodstrom-Tullberg M; Mallone R
Article: NATURE COMMUNICATIONS. 2024;15(1):1752
Intestinal stroma guides monocyte differentiation to macrophages through GM-CSF
Kvedaraite E; Lourda M; Mouratidou N; Duking T; Padhi A; Moll K; Czarnewski P; Sinha I; Xagoraris I; Kokkinou E; Damdimopoulos A; Weigel W; Hartwig O; Santos TE; Soini T; Van Acker A; Rahkonen N; Tullberg MF; Ringqvist E; Buggert M; Jorns C; Lindforss U; Nordenvall C; Stamper CT; Unnersjoe-Jess D; Akber M; Nadisauskaite R; Jansson J; Vandamme N; Sorini C; Grundeken ME; Rolandsdotter H; Rassidakis G; Villablanca EJ; Idestroem M; Eulitz S; Arnell H; Mjoesberg J; Henter J-I; Svensson M
Journal article: BIORXIV. 2023;:2023.08.19.553954
Coxsackievirus infection induces direct pancreatic β-cell killing but poor anti-viral CD8+ T-cell responses.
Vecchio F; Carré A; Korenkov D; Zhou Z; Apaolaza P; Tuomela S; Burgos-Morales O; Snowhite I; Perez-Hernandez J; Brandao B; Afonso G; Halliez C; Kaddis J; Kent SC; Nakayama M; Richardson SJ; Vinh J; Verdier Y; Laiho J; Scharfmann R; Solimena M; Marinicova Z; Bismuth E; Lucidarme N; Sanchez J; Bustamante C; Gomez P; Buus S; nPOD-Virus Working Group; You S; Pugliese A; Hyoty H; Rodriguez-Calvo T; Flodstrom-Tullberg M; Mallone R
Journal article: JOURNAL OF IMMUNOLOGY. 2023;210(1):141.13
Characterization of immune response towards modified Coxsackie B virus-like particle vaccine in a murine model
Soppela SM; Gonzalez-Rodriguez M; Stone V; Kummola L; Lampinen V; Jouppila N; Laitinen O; Flodstrom-Tullberg M; Junttila I; Hankaniemi M
Article: RESPIRATORY RESEARCH. 2023;24(1):62
Targeted plasma proteomics reveals signatures discriminating COVID-19 from sepsis with pneumonia
Palma Medina LM; Babacic H; Dzidic M; Parke A; Garcia M; Maleki KT; Unge C; Lourda M; Kvedaraite E; Chen P; Muvva JR; Cornillet M; Emgard J; Moll K; Michaelsson J; Flodstrom-Tullberg M; Brighenti S; Buggert M; Mjosberg J; Malmberg K-JK; Sandberg J; Gredmark-Russ S; Rooyackers O; Svensson MJ; Chambers BI; Eriksson L; Pernemalm MK; Bjorkstrom N; Aleman S; Ljunggren H-G; Klingstrom J; Stralin K; Norrby-Teglund A
Article: ISCIENCE. 2022;25(10):105070
Coxsackievirus B infections are common in Cystic Fibrosis and experimental evidence supports protection by vaccination
Stone VM; Utorova R; Butrym M; Sioofy-Khojine A-B; Hankaniemi MM; Ringqvist EE; Blanter M; Parajuli A; Pincikova T; Fischler B; Karpati F; Hytonen VP; Hyoty H; Hjelte L; Flodstrom-Tullberg M
Article: FRONTIERS IN ENDOCRINOLOGY. 2022;13:971313
Proteome profiling of whole plasma and plasma-derived extracellular vesicles facilitates the detection of tissue biomarkers in the non-obese diabetic mouse
Lozano IMD; Sork H; Stone VM; Eldh M; Cao X; Pernemalm M; Gabrielsson S; Flodstrom-Tullberg M
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2022;96(1):e13195
The Karolinska KI/K COVID-19 immune atlas: An open resource for immunological research and educational purposes
Ljunggren H-G; Heggernes Ask E; Cornillet Jeannin M; Strunz B; Chen P; Rao Muvva J; Akber M; Buggert M; Chambers BJ; Cuapio Gomez A; Dzidic M; Filipovic I; Flodstrom-Tullberg M; Garcia M; Gorin J-B; Gredmark-Russ S; Hertwig L; Klingstrom J; Kokkinou E; Kvedaraite E; Lourda M; Mjosberg J; Maucourant C; Norrby-Teglund A; Palma Medina LM; Parrot T; Perez-Potti A; Ponzetta A; Ringqvist E; Rivera-Ballesteros O; Rooyackers O; Sandberg JK; Sandberg JT; Sekine T; Svensson M; Varnaite R; Wullimann D; Eriksson LI; Aleman S; Malmberg K-J; Stralin K; Bjorkstrom NK
Article: DIABETES. 2021;70(12):2871-2878
Coxsackievirus B Vaccines Prevent Infection-Accelerated Diabetes in NOD Mice and Have No Disease-Inducing Effect
Stone VM; Butrym M; Hankaniemi MM; Sioofy-Khojine A-B; Hytonen VP; Hyoty H; Flodstrom-Tullberg M
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2021;118(40):e2109123118
High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of in COVID-19
Lourda M; Dzidic M; Hertwig L; Bergsten H; Medina LMP; Sinha I; Kvedaraite E; Chen P; Muvva JR; Gorin J-B; Cornillet M; Emgard J; Moll K; Garcia M; Maleki KT; Klingstrom J; Michaelsson J; Flodstrom-Tullberg M; Brighenti S; Buggert M; Mjosberg J; Malmberg K-J; Sandberg JK; Henter J-I; Folkesson E; Gredmark-Russ S; Sonnerborg A; Eriksson LI; Rooyackers O; Aleman S; Stralin K; Ljunggren H-G; Bjorkstrom NK; Svensson M; Ponzetta A; Norrby-Teglund A; Chambers BJ
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2021;118(6):e2018587118
Major alterations in the mononuclear phagocyte landscape associated with COVID-19 severity
Kvedaraite E; Hertwig L; Sinha I; Ponzetta A; Myrberg IH; Lourda M; Dzidic M; Akber M; Klingstrom J; Folkesson E; Muvva JR; Chen P; Gredmark-Russ S; Brighenti S; Norrby-Teglund A; Eriksson LI; Rooyackers O; Aleman S; Stralin K; Ljunggren H-G; Ginhoux F; Bjorkstrom NK; Henter J-I; Svensson M
Article: MICROORGANISMS. 2021;9(1):E105-105
Inhibition of Type III Interferon Expression in Intestinal Epithelial Cells-A Strategy Used by Coxsackie B Virus to Evade the Host's Innate Immune Response at the Primary Site of Infection?
Stone VM; Ringqvist EE; Larsson PG; Domsgen E; Holmlund U; Sverremark-Ekstrom E; Flodstrom-Tullberg M
Article: CLINICAL & TRANSLATIONAL IMMUNOLOGY. 2021;10(7):e1306
SARS-CoV-2-specific humoral and cellular immunity persists through 9 months irrespective of COVID-19 severity at hospitalisation
Sandberg JT; Varnaite R; Christ W; Chen P; Muvva JR; Maleki KT; Garcia M; Dzidic M; Folkesson E; Skagerberg M; Ahlen G; Frelin L; Sallberg M; Eriksson LI; Rooyackers O; Sonnerborg A; Buggert M; Bjorkstrom NK; Aleman S; Stralin K; Klingstrom J; Ljunggren H-G; Blom K; Gredmark-Russ S
Article: FRONTIERS IN PUBLIC HEALTH. 2020;8:562901
Corona Pandemic: Assisted Isolation and Care to Protect Vulnerable Populations May Allow Us to Shorten the Universal Lock-Down and Gradually Re-open Society
Ludvigsson J; von Herrath MG; Mallone R; Buschard K; Cilio C; Craig M; Ilonen J; Leslie D; McGeoch JEM; Schneider D; Skyler JS; Flodstrom Tullberg M; Hober D
Article: SCIENCE IMMUNOLOGY. 2020;5(51):eabe1670
MAIT cell activation and dynamics associated with COVID-19 disease severity
Parrot T; Gorin J-B; Ponzetta A; Maleki KT; Kammann T; Emgard J; Perez-Potti A; Sekine T; Rivera-Ballesteros O; Gredmark-Russ S; Rooyackers O; Folkesson E; Eriksson LI; Norrby-Teglund A; Ljunggren H-G; Bjorkstrom NK; Aleman S; Buggert M; Klingstrom J; Stralin K; Sandberg JK
Article: PLOS PATHOGENS. 2020;16(9):e1008927
Defining the proteolytic landscape during enterovirus infection
Saeed M; Kapell S; Hertz NT; Wu X; Bell K; Ashbrook AW; Mark MT; Zebroski HA; Neal ML; Flodstrom-Tullberg M; MacDonald MR; Aitchison JD; Molina H; Rice CM
Article: MICROORGANISMS. 2020;8(9):E1287-1287
Structural Insight into CVB3-VLP Non-Adjuvanted Vaccine
Hankaniemi MM; Baikoghli MA; Stone VM; Xing L; Vaatainen O; Soppela S; Sioofy-Khojine A; Saarinen NVV; Ou T; Anson B; Hyoty H; Marjomaki V; Flodstrom-Tullberg M; Cheng RH; Hytonen VP; Laitinen OH
Article: SCIENCE IMMUNOLOGY. 2020;5(50):eabd6832
Natural killer cell immunotypes related to COVID-19 disease severity
Maucourant C; Filipovic I; Ponzetta A; Aleman S; Cornillet M; Hertwig L; Strunz B; Lentini A; Reinius B; Brownlie D; Cuapio A; Ask EH; Hull RM; Haroun-Izquierdo A; Schaffer M; Klingstrom J; Folkesson E; Buggert M; Sandberg JK; Eriksson LI; Rooyackers O; Ljunggren H-G; Malmberg K-J; Michaelsson J; Marquardt N; Hammer Q; Stralin K; Bjorkstrom NK
Journal article: JOURNAL OF CYSTIC FIBROSIS. 2020;19:s128-s129
P257 Assessing possible role of enterovirus infections in diabetes onset in a Swedish cohort of cystic fibrosis patients
Utorova R; Khojine AS; Pincikova T; Hjelte L; Hyöty H; Flodström-Tullberg M
Article: SCIENCE ADVANCES. 2020;6(19):eaaz2433
A hexavalent Coxsackievirus B vaccine is highly immunogenic and has a strong protective capacity in mice and nonhuman primates
Stone VM; Hankaniemi MM; Laitinen OH; Sioofy-Khojine AB; Lin A; Lozano IMD; Mazur MA; Marjomaki V; Lore K; Hyoty H; Hytonen VP; Flodstrom-Tullberg M
Article: VIRUSES-BASEL. 2020;12(1):E78-78
Antibody Responses against Enterovirus Proteases are Potential Markers for an Acute Infection
Saarinen NVV; Stone VM; Hankaniemi MM; Mazur MA; Vuorinen T; Flodstrom-Tullberg M; Hyoty H; Hytonen VP; Laitinen OH
Article: JOURNAL OF VIROLOGY. 2020;94(2):e01393-e01319
Human Enterovirus Group B Viruses Rely on Vimentin Dynamics for Efficient Processing of Viral Nonstructural Proteins
Turkki P; Laajala M; Flodstrom-Tullberg M; Marjomaki V
Article: METHODS IN MOLECULAR BIOLOGY. 2020;2128:93-105
Mouse Models of Virus-Induced Type 1 Diabetes.
Christoffersson G; Flodström-Tullberg M
Article: ANTIVIRAL RESEARCH. 2019;171:104595
Formalin treatment increases the stability and immunogenicity of coxsackievirus B1 VLP vaccine
Hankaniemi MM; Stone VM; Andrejeff T; Heinimaki S; Sioofy-Khojine A-B; Marjomaki V; Hyoty H; Blazevic V; Flodstrom-Tullberg M; Hytonen VP; Laitinen OH
Article: ISCIENCE. 2019;19:340-357
Coxsackievirus B Persistence Modifies the Proteome and the Secretome of Pancreatic Ductal Cells
Lietzen N; Hirvonen K; Honkimaa A; Buchacher T; Laiho JE; Oikarinen S; Mazur MA; Flodstrom-Tullberg M; Dufour E; Sioofy-Khojine A-B; Hyoty H; Lahesmaa R
Article: VACCINE. 2019;37(40):5962-5971
A comparative study of the effect of UV and formalin inactivation on the stability and immunogenicity of a Coxsackievirus B1 vaccine
Hankaniemi MM; Stone VM; Sioofy-Khojine A-B; Heinimaki S; Marjomaki V; Hyoty H; Blazevic V; Laitinen IH; Flodstrom-Tullberg M; Hytonen VP
Article: SCIENTIFIC REPORTS. 2019;9(1):11244
Short-term CFTR inhibition reduces islet area in C57BL/6 mice
Khan D; Kelsey R; Maheshwari RR; Stone VM; Hasib A; Koivula FNM; Watson A; Harkin S; Irwin N; Shaw JA; McClenaghan NH; Venglovecz V; Ebert A; Flodstrom-Tullberg M; White MG; Kelly C
Article: DIABETOLOGIA. 2019;62(5):744-753
Rationale for enteroviral vaccination and antiviral therapies in human type 1 diabetes
Dunne JL; Richardson SJ; Atkinson MA; Craig ME; Dahl-Jorgensen K; Flodstrom-Tullberg M; Hyoty H; Insel RA; Lernmark A; Lloyd RE; Morgan NG; Pugliese A
Article: JOURNAL OF ENDOCRINOLOGY. 2019;241(1):45-57
Defective exocytosis and processing of insulin in a cystic fibrosis mouse model
Edlund A; Barghouth M; Huhn M; Abels M; Esguerra JSE; Mollet IG; Svedin E; Wendt A; Renstrom E; Zhang E; Wierup N; Scholte BJ; Flodstrom-Tullberg M; Eliasson L
Article: CHEST. 2018;153(5):e93-e96
Severely Impaired Control of Bacterial Infections in a Patient With Cystic Fibrosis Defective in Mucosal-Associated Invariant T Cells.
Pincikova T; Paquin-Proulx D; Moll M; Flodström-Tullberg M; Hjelte L; Sandberg JK
Article: JOURNAL OF VIROLOGICAL METHODS. 2018;255:29-37
New Coxsackievirus 2A^pro and 3C^pro protease antibodies for virus detection and discovery of pathogenic mechanisms
Laitinen OH; Svedin E; Kapell S; Hankaniemi MM; Larsson PG; Domsgen E; Stone VM; Maatta JAE; Hyoty H; Hytonen VP; Flodstrom-Tullberg M
Article: DIABETOLOGIA. 2018;61(2):476-481
A Coxsackievirus B vaccine protects against virus-induced diabetes in an experimental mouse model of type 1 diabetes
Stone VM; Hankaniemi MM; Svedin E; Sioofy-Khojine A; Oikarinen S; Hyoty H; Laitinen OH; Hytonen VP; Flodstrom-Tullberg M
Article: SCIENTIFIC REPORTS. 2018;8(1):33
A novel rat CVB1-VP1 monoclonal antibody 3A6 detects a broad range of enteroviruses
Saarinen NVV; Laiho JE; Richardson SJ; Zeissler M; Stone VM; Marjomaki V; Kantoluoto T; Horwitz MS; Sioofy-Khojine A; Honkimaa A; Hankaniemi MM; Flodstrom-Tullberg M; Hyoty H; Hytonen VP; Laitinen OH
Article: JOURNAL OF INFECTIOUS DISEASES. 2017;216(10):1308-1317
A Link Between a Common Mutation in CFTR and Impaired Innate and Adaptive Viral Defense
Svedin E; Utorova R; Huhn MH; Larsson PG; Stone VM; Garimella M; Lind K; Hagglof T; Pincikova T; Laitinen OH; McInerney GM; Scholte B; Hjelte L; Karlsson MCI; Flodstrom-Tullberg M
Article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2017;189(3):359-371
Vitamin D treatment modulates immune activation in cystic fibrosis
Pincikova T; Paquin-Proulx D; Sandberg JK; Flodstrom-Tullberg M; Hjelte L
Article: EUROPEAN JOURNAL OF IMMUNOLOGY. 2017;47(8):1280-1294
Composition and functionality of the intrahepatic innate lymphoid cell-compartment in human nonfibrotic and fibrotic livers
Forkel M; Berglin L; Kekalainen E; Carlsson A; Svedin E; Michaelsson J; Nagasawa M; Erjefalt JS; Mori M; Flodstrom-Tullberg M; Bergquist A; Ljunggren H-G; Westgren M; Lindforss U; Friberg D; Jorns C; Ellis E; Bjorkstrom NK; Mjosberg J
Article: VACCINE. 2017;35(30):3718-3725
Optimized production and purification of Coxsackievirus B1 vaccine and its preclinical evaluation in a mouse model
Hankaniemi MM; Laitinen OH; Stone VM; Sioofy-Khojine A; Maatta JAE; Larsson PG; Marjomaki V; Hyoty H; Flodstrom-Tullberg M; Hytonen VP
Journal article: JOURNAL OF CYSTIC FIBROSIS. 2017;16:s86
84 Unexpectedly severe infection susceptibility in a CF patient defective in MAIT cells
Pincikova T; Paquin-Proulx D; Moll M; Flodström-Tullberg M; Hjelte L; Sandberg JK
Article: SCIENTIFIC REPORTS. 2017;7(1):90
CFTR is involved in the regulation of glucagon secretion in human and rodent alpha cells
Edlund A; Pedersen MG; Lindqvist A; Wierup N; Flodstrom-Tullberg M; Eliasson L
Article: EUROPEAN JOURNAL OF CLINICAL NUTRITION. 2017;71(2):203-205
Clinical impact of vitamin D treatment in cystic fibrosis: a pilot randomized, controlled trial
Pincikova T; Paquin-Proulx D; Sandberg JK; Flodstrom-Tullberg M; Hjelte L
Article: SCIENTIFIC REPORTS. 2016;6:39378
An IFIH1 gene polymorphism associated with risk for autoimmunity regulates canonical antiviral defence pathways in Coxsackievirus infected human pancreatic islets
Domsgen E; Lind K; Kong L; Huhn MH; Rasool O; van Kuppeveld F; Korsgren O; Lahesmaa R; Flodstrom-Tullberg M
Article: VIRAL IMMUNOLOGY. 2016;29(7):389-397
Enterovirus Exposure Uniquely Discriminates Type 1 Diabetes Patients with a Homozygous from a Heterozygous Melanoma Differentiation-Associated Protein 5/Interferon Induced with Helicase C Domain 1 A946T Genotype
Schulte BM; Gielen PR; Kers-Rebel ED; Prosser AC; Lind K; Flodstrom-Tullberg M; Tack CJ; Elving LD; Adema GJ
Article: ACTA PAEDIATRICA. 2016;105(7):851-853
Cystic fibrosis bronchial epithelial cells have impaired ability to activate vitamin D
Pincikova T; Svedin E; Domsgen E; Flodstrom-Tullberg M; Hjelte L
Journal article: JOURNAL OF CYSTIC FIBROSIS. 2016;15:s10
WS06.4 The CFTR™1Eur mouse has a delayed type I interferon response following stimulation with polyinosinic:polycytidylic acid (polyI:C)
Utorova R; Svedin E; Scholte BJ; Flodström-Tullberg M
Article: JOURNAL OF GENERAL VIROLOGY. 2016;97(6):1368-1380
Coxsackievirus counters the host innate immune response by blocking type III interferon expression
Lind K; Svedin E; Domsgen E; Kapell S; Laitinen OH; Moll M; Flodstrom-Tullberg M
Article: IMMUNOLOGY AND CELL BIOLOGY. 2016;94(2):177-184
Depletion of IL-2 receptor β-positive cells protects from diabetes in non-obese diabetic mice
Brauner H; Hall HT; Flodstrom-Tullberg M; Karre K; Hoglund P; Johansson S
Article: JOURNAL OF CLINICAL VIROLOGY. 2015;69:165-171
Application of bioinformatics in probe design enables detection of enteroviruses on different taxonomic levels by advanced in situ hybridization technology
Laiho JE; Oikarinen S; Oikarinen M; Larsson PG; Stone VM; Hober D; Oberste S; Flodstrom-Tullberg M; Isola J; Hyoty H
Article: DIABETOLOGIA. 2015;58(2):346-354
A preclinical study on the efficacy and safety of a new vaccine against Coxsackievirus B1 reveals no risk for accelerated diabetes development in mouse models
Larsson PG; Lakshmikanth T; Laitinen OH; Utorova R; Jacobson S; Oikarinen M; Domsgen E; Koivunen MRL; Chaux P; Devard N; Lecouturier V; Almond J; Knip M; Hyoty H; Flodstrom-Tullberg M
Article: JOURNAL OF BIOLOGICAL CHEMISTRY. 2014;289(44):30614-30624
Novel Role for Matricellular Proteins in the Regulation of Islet β Cell Survival THE EFFECT OF SPARC ON SURVIVAL, PROLIFERATION, AND SIGNALING
Ryall CL; Viloria K; Lhaf F; Walker AJ; King A; Jones P; Mackintosh D; McNeice R; Kocher H; Flodstrom-Tullberg M; Edling C; Hill NJ
Article: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2014;177(3):687-695
Type III interferons are expressed by Coxsackievirus-infected human primary hepatocytes and regulate hepatocyte permissiveness to infection
Lind K; Svedin E; Utorova R; Stone VM; Flodstrom-Tullberg M
Journal article: JOURNAL OF CYSTIC FIBROSIS. 2014;13:s32
WS15.4 Cystic fibrosis bronchial epithelial cells have impaired ability to activate vitamin D
Pincikova T; Flodström-Tullberg M; Hjelte L
Journal article: JOURNAL OF CYSTIC FIBROSIS. 2014;13:s75
113 Increased susceptibility to enterovirus infections in a model for cystic fibrosis is associated with an impaired innate and adaptive antiviral immune response
Svedin E; Hühn MH; Utorova R; Larsson P; Lind K; Pincikova T; Scholte BJ; Hjelte L; Flodström-Tullberg M
Journal article: JOURNAL OF CYSTIC FIBROSIS. 2014;13:s26
WS12.6 CFTR is an essential component in cAMP-dependent exocytosis in human and mouse beta-cell insulin secretion
Eliasson L; Edlund A; Esguerra JL; Wendt A; Flodström-Tullberg M
Article: BMC MEDICINE. 2014;12:87
CFTR and Anoctamin 1 (ANO1) contribute to cAMP amplified exocytosis and insulin secretion in human and murine pancreatic beta-cells
Edlund A; Esguerra JLS; Wendt A; Flodstrom-Tullberg M; Eliasson L
Article: DIABETOLOGIA. 2014;57(2):392-401
Evaluation of the fidelity of immunolabelling obtained with clone 5D8/1, a monoclonal antibody directed against the enteroviral capsid protein, VP1, in human pancreas
Richardson SJ; Leete P; Dhayal S; Russell MA; Oikarinen M; Laiho JE; Svedin E; Lind K; Rosenling T; Chapman N; Bone AJ; Foulis AK; Frisk G; Flodstrom-Tullberg M; Hober D; Hyoty H; Morgan NG
Article: DIABETES. 2013;62(11):3785-3796
Protection Against Type 1 Diabetes Upon Coxsackievirus B4 Infection and iNKT-Cell Stimulation
Ghazarian L; Diana J; Beaudoin L; Larsson PG; Puri RK; van Rooijen N; Flodstrom-Tullberg M; Lehuen A
Article: JOURNAL OF VIROLOGY. 2013;87(13):7646-7654
Induction of an Antiviral State and Attenuated Coxsackievirus Replication in Type III Interferon-Treated Primary Human Pancreatic Islets
Lind K; Richardson SJ; Leete P; Morgan NG; Korsgren O; Flodstrom-Tullberg M
Journal article: JOURNAL OF CYSTIC FIBROSIS. 2013;12:s32
WS16.3 Vitamin D supplementation in patients with cystic fibrosis: A pilot randomized controlled trial
Pincikova T; Flodström-Tullberg M; Hjelte L
Article: DIABETOLOGIA. 2013;56(4):867-874
Previous maternal infection protects offspring from enterovirus infection and prevents experimental diabetes development in mice
Larsson PG; Lakshmikanth T; Svedin E; King C; Flodstrom-Tullberg M
Article: CELL TRANSPLANTATION. 2013;22(7):1137-1146
The TheraCyte™ Device Protects Against Islet Allograft Rejection in Immunized Hosts
Kumagai-Braesch M; Jacobson S; Mori H; Jia X; Takahashi T; Wernerson A; Flodstrom-Tullberg M; Tibell A
Article: FASEB JOURNAL. 2012;26(8):3282-3291
SOCS2 deletion protects against hepatic steatosis but worsens insulin resistance in high-fat-diet-fed mice
Zadjali F; Santana-Farre R; Vesterlund M; Carow B; Mirecki-Garrido M; Hernandez-Hernandez I; Flodstrom-Tullberg M; Parini P; Rottenberg M; Norstedt G; Fernandez-Perez L; Flores-Morales A
Journal article: JOURNAL OF CYSTIC FIBROSIS. 2011;10:s69
270* Neuroendocrine characterization of the intestine of F508del CFTR mice
Hielte L; Flodström-Tullberg M; Nilsson Å; Wierup N; Sundler F
Journal article: TRANSPLANT IMMUNOLOGY. 2011;24(3):181-188
Beta-cell specific expression of suppressor of cytokine signaling-1 (SOCS-1) delays islet allograft rejection by down-regulating Interferon Regulatory Factor-1 (IRF-1) signaling
Solomon M; Flodstroem-Tullberg M; Sarvetnick N
Article: BLOOD. 2010;116(19):3853-3864
Expression patterns of NKG2A, KIR, and CD57 define a process of CD56^dim NK-cell differentiation uncoupled from NK-cell education
Bjorkstrom NK; Riese P; Heuts F; Andersson S; Fauriat C; Ivarsson MA; Bjorklund AT; Flodstrom-Tullberg M; Michaelsson J; Rottenberg ME; Guzman CA; Ljunggren H-G; Malmberg K-J
Article: VIROLOGY. 2010;401(1):42-48
Melanoma differentiation-associated protein-5 (MDA-5) limits early viral replication but is not essential for the induction of type 1 interferons after Coxsackievirus infection
Huhn MH; McCartney SA; Lind K; Syedin E; Colonna M; Flodstrom-Tullberg M
Article: JOURNAL OF IMMUNOLOGY. 2010;184(5):2272-2280
Distinct Phenotype and Function of NK Cells in the Pancreas of Nonobese Diabetic Mice
Brauner H; Elemans M; Lemos S; Broberger C; Holmberg D; Flodstrom-Tullberg M; Karre K; Hoglund P
Article: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2010;71(2):83-90
Alloreactivity but failure to reject human islet transplants by humanized Balb/c/Rag2gc mice.
Jacobson S; Heuts F; Juarez J; Hultcrantz M; Korsgren O; Svensson M; Rottenberg M; Flodström-Tullberg M
Article: CELLULAR AND MOLECULAR LIFE SCIENCES. 2009;66(23):3787-3795
Suppressor of cytokine signaling-1 inhibits caspase activation and protects from cytokine-induced beta cell death
Zaitseva II; Hultcrantz M; Sharoyko V; Flodstrom-Tullberg M; Zaitsev SV; Berggren P-O
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2009;106(46):19438-19443
Loss of parity between IL-2 and IL-21 in the NOD Idd3 locus
McGuire HM; Vogelzang A; Hill N; Flodstrom-Tullberg M; Sprent J; King C
Article: DIABETOLOGIA. 2009;52(2):299-305
The target cell response to cytokines governs the autoreactive T cell repertoire in the pancreas of NOD mice.
Hultcrantz M; Jacobson S; Hill NJ; Santamaria P; Flodström-Tullberg M
Article: JOURNAL OF PEDIATRIC GASTROENTEROLOGY AND NUTRITION. 2008;47(5):547-554
Expression of Intestinal and Lung Alkaline Sphingomyelinase and Neutral Ceramidase in Cystic Fibrosis F508del Transgenic Mice
Ohlsson L; Hjelte L; Huhn M; Scholte BJ; Wilke M; Flodstrom-Tullberg M; Nilsson A
Article: CELLULAR MICROBIOLOGY. 2008;10(2):426-436
IFN-γ production dominates the early human natural killer cell response to Coxsackievirus infection
Huhn MH; Hultcrantz M; Lind K; Ljunggren H-G; Malmberg K-J; Flodstrom-Tullberg M
Article: VIROLOGY. 2007;367(1):92-101
Interferons induce an antiviral state in human pancreatic islet cells
Hultcrantz M; Huhn MH; Wolf M; Olsson A; Jacobson S; Williams BR; Korsgren O; Flodstrom-Tullberg M
Article: JOURNAL OF IMMUNOLOGY. 2005;174(3):1171-1177
RNase L and double-stranded RNA-dependent protein kinase exert complementary roles in islet cell defense during coxsackievirus infection
Flodström-Tullberg M; Hultcrantz M; Stotland A; Maday A; Tsai D; Fine C; Williams B; Silverman R; Sarvetnick N
Article: JOURNAL OF IMMUNOLOGY. 2004;173(6):3631-3639
B7-2 (CD86) controls the priming of autoreactive CD4 T cell response against pancreatic islets
Yadav D; Judkowski V; Flodstrom-Tullberg M; Sterling L; Redmond WL; Sherman L; Sarvetnick N
Journal article: TRANSPLANTATION. 2004;78(2):109-110
CONSTITUTIVE EXPRESSION OF SUPPRESSOR OF CYTOKINE SIGNALING-1 (SOCS-1) IN PANCREATIC ISLETS DELAYS ISLET ALLOGRAFT REJECTION.
Solomon M; Flodström-Tullberg M; Sarvetnick N
Article: MOLECULAR IMMUNOLOGY. 2004;40(14-15):1109-1112
Strong attraction may be dangerous: parameters for the development of long term commitment
Judkowski V; Pinilla C; Alicotti G; Flödstrom M; Sanna P; Sarvetnick N
Article: JOURNAL OF CELL BIOLOGY. 2003;163(4):859-869
The stromal cell-derived factor-1α/CXCR4 ligand-receptor axis is critical for progenitor survival and migration in the pancreas
Kayali AG; Van Gunst K; Campbell IL; Stotland A; Kritzik M; Liu GX; Flodström-Tullberg M; Zhang YQ; Sarvetnick N
Article: DIABETES. 2003;52(11):2696-2700
Target cell expression of suppressor of cytokine signaling-1 prevents diabetes in the NOD mouse
Flodström-Tullberg M; Yadav D; Hagerkvist R; Tsai D; Secrest P; Stotland A; Sarvetnick N
Article: DIABETES. 2003;52(8):2025-2034
Diabetogenic potential of human pathogens uncovered in experimentally permissive β-cells
Flodström M; Tsai D; Fine C; Maday A; Sarvetnick N
Article: NATURE IMMUNOLOGY. 2002;3(4):373-382
Target cell defense prevents the development of diabetes after viral infection
Flodström M; Maday A; Balakrishna D; Cleary MM; Yoshimura A; Sarvetnick N
Article: JOURNAL OF IMMUNOLOGY. 2001;167(5):3000-3006
Control of the autoimmune response by type 2 nitric oxide synthase
Shi FD; Flodström M; Kim SH; Pakala S; Cleary M; Ljunggren HG; Sarvetnick N
Article: PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA. 2001;98(12):6777-6782
Germ line deletion of the CD1 locus exacerbates diabetes in the NOD mouse
Shi FD; Flodström M; Balasa B; Kim SH; Van Gunst K; Strominger JL; Wilson SB; Sarvetnick N
Article: VIROLOGY. 2001;281(2):205-215
Critical role for inducible nitric oxide synthase in host survival following coxsackievirus B4 infection
Flodström M; Horwitz MS; Maday A; Balakrishna D; Rodriguez E; Sarvetnick N
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 2001;281(2):396-403
Cytokine-induced inhibition of insulin release from mouse pancreatic β-cells deficient in inducible nitric oxide synthase
Andersson AK; Flodström M; Sandler S
Article: ENDOCRINOLOGY. 2000;141(8):2752-2757
Islet Blood Flow in Multiple Low Dose Streptozotocin-Treated Wild-Type and Inducible Nitric Oxide Synthase-Deficient Mice.
Carlsson P-O; Flodstro M M; Sandler S
Article: ENDOCRINOLOGY. 2000;141(8):2752-2757
Islet blood flow in multiple low dose streptozotocin-treated wild-type and inducible nitric oxide synthase-deficient mice
Carlsson PO; Flodström M; Sandler S
Article: DIABETES. 2000;49(7):1116-1122
Cytokines induce apoptosis in β-cells isolated from mice lacking the inducible isoform of nitric oxide synthase (iNOS^-/-)
Liu DB; Pavlovic D; Chen MC; Flodström M; Sandler S; Eizirik DL
Article: CYTOKINE. 1999;11(6):400-407
Interleukin 1β increases arginine accumulation and activates the citrulline-NO cycle in rat pancreatic β cells
Flodström M; Chen MC; Smismans A; Schuit F; Pipeleers DG; Eizirik DL
Article: DIABETES. 1999;48(4):706-713
Reduced sensitivity of inducible nitric oxide synthase-deficient mice to multiple low-dose streptozotocin-induced diabetes
Flodström M; Tyrberg B; Eizirik DL; Sandler S
Article: JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM. 1997;82(8):2660-2663
Mechanisms of defective glucose-induced insulin release in human pancreatic islets transplanted to diabetic nude mice
Eizirik DL; Jansson L; Flodstrom M; Hellerstrom C; Andersson A
Article: ENDOCRINOLOGY. 1997;138(7):2747-2753
Interferon-gamma-induced interferon regulatory factor-1 (IRF-1) expression in rodent and human islet cells precedes nitric oxide production
Flodstrom M; Eizirik DL
Article: BIOCHEMICAL PHARMACOLOGY. 1996;52(11):1703-1709
Ebselen and cytokine-induced nitric oxide synthase expression in insulin-producing cells
deMello MAR; Flodstrom M; Eizirik DL
Article: CYTOKINE. 1996;8(8):642-650
Role of the citrulline-nitric oxide cycle in the functional response of adult human and rodent pancreatic islets to cytokines
Flodstrom M; Morris SM; Eizirik DL
Article: FEBS LETTERS. 1996;385(1-2):4-6
Cytokines activate the nuclear factor kappa B (NF-kappa B) and induce nitric oxide production in human pancreatic islets
Flodstrom M; Welsh N; Eizirik DL
Article: MOLECULAR MEDICINE. 1995;1(7):806-820
DIFFERENCES IN THE EXPRESSION OF HEAT-SHOCK PROTEINS AND ANTIOXIDANT ENZYMES BETWEEN HUMAN AND RODENT PANCREATIC-ISLETS - IMPLICATIONS FOR THE PATHOGENESIS OF INSULIN-DEPENDENT DIABETES-MELLITUS
WELSH N; MARGULIS B; BORG LAH; WIKLUND HJ; SALDEEN J; FLODSTROM M; MELLO MA; ANDERSSON A; PIPELEERS DG; HELLERSTROM C; EIZIRIK DL
Article: ENDOCRINOLOGY. 1995;136(8):3200-3206
EXPRESSION OF THE CITRULLINE-NITRIC OXIDE CYCLE IN RODENT AND HUMAN PANCREATIC BETA-CELLS - INDUCTION OF ARGININOSUCCINATE SYNTHETASE BY CYTOKINES
FLODSTROM M; NIEMANN A; BEDOYA FJ; MORRIS SM; EIZIRIK DL
Article: BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS. 1995;210(3):816-822
PYRROLIDINE DITHIOCARBAMATE PREVENTS IL-1-INDUCED NITRIC-OXIDE SYNTHASE MESSENGER-RNA, BUT NOT SUPEROXIDE-DISMUTASE MESSENGER-RNA, IN INSULIN-PRODUCING CELLS
BEDOYA FJ; FLODSTROM M; EIZIRIK DL
Visa fler

Alla övriga publikationer

Preprint: BIORXIV. 2024
Longitudinal blood microsampling and proteome monitoring facilitate timely intervention in experimental type 1 diabetes
Parajuli A; Bendes A; Byvald F; Stone VM; Ringqvist EE; Butrym M; Angelis E; Kipper S; Bauer S; Roxhed N; Schwenk JM; Flodström-Tullberg M
Review: JOURNAL OF BIOMEDICAL SCIENCE. 2024;31(1):73
Enteroviruses: epidemic potential, challenges and opportunities with vaccines
Jartti M; Flodstrom-Tullberg M; Hankaniemi MM
Preprint: BIORXIV. 2024
Production, analysis, and safety assessment of a soil and plant-based natural material with microbiome- and immune-modulatory effects
Parajuli A; Mäkela I; Roslund M; Ringqvist E; Manninen J; Sun Y; Nurminen N; Oikarinen S; Laitinen O; Hyöty H; Flodström-Tullberg M; Sinkkonen A
Review: ENDOCRINE REVIEWS. 2023;44(4):737-751
Coxsackievirus and Type 1 Diabetes: Diabetogenic Mechanisms and Implications for Prevention
Carre A; Vecchio F; Flodstrom-Tullberg M; You S; Mallone R
Conference publication: DIABETOLOGIA. 2022;65(SUPPL 1):S199
Proteome profiling of whole plasma and plasma-derived extracellular vesicles facilitates the detection of tissue biomarkers in the NOD mouse
Stone VM; Lozano ID; Sork H; Eldh M; Pernemalm M; Gabrielsson S; Flodstrom-Tullberg M
Editorial comment: TRENDS IN MICROBIOLOGY. 2022;30(6):606-607
Coxsackie B virus
Marjomaki V; Flodstrom-Tullberg M
Conference publication: DIABETOLOGIA. 2021;64(SUPPL 1):155-156
A multivalent vaccine does not accelerate the onset of diabetes in NOD mice
Stone VM; Butrym M; Hankaniemi MM; Sioofy-Khojine A-B; Hytonen VP; Hyoty H; Flodstrom-Tullberg M
Conference publication: DIABETOLOGIA. 2021;64(SUPPL 1):114
Type III interferons are expressed in human pancreas at type 1 diabetes onset and induce immunostimulatory and antiviral activities in human beta cells
Ringqvist EE; Tuomela S; Mazur M; Burdsall K; Parajuli A; Sork H; Krogvold L; Dahl-Jorgensen K; Matthews C; Gerling I; Flodstrom-Tullberg M
Preprint: MEDRXIV. 2021
High-dimensional profiling reveals phenotypic heterogeneity and disease-specific alterations of granulocytes in COVID-19
Lourda M; Dzidic M; Hertwig L; Bergsten H; Medina LP; Kvedaraite E; Chen P; Muvva J; Gorin J-B; Cornillet M; Emgård J; Moll K; García M; Maleki K; Klingström J; Michaëlsson J; Flodström-Tullberg M; Brighenti S; Buggert M; Mjösberg J; Malmberg K-J; Sandberg J; Henter J-I; Folkesson E; Gredmark-Russ S; Sönnerborg A; Eriksson L; Rooyackers O; Aleman S; Strålin K; Ljunggren H-G; Björkström N; Svensson M; Ponzetta A; Norrby-Teglund A; Chambers B; the Karolinska KI/K COVID-19 Study Group
Preprint: BIORXIV. 2019
GLP-1R is downregulated in beta cells of NOD mice and T1D patients
Recino A; Barkan K; Schmidt-Christensen A; Nilsson J; Holmes N; Howie D; Holmberg D; Larsson P; Flodström-Tullberg M; Laraia L; Spring D; Hecksher-Sørensen J; Cooke A; Ladds G; Wållberg M
Review: CURRENT DIABETES REPORTS. 2019;19(9):82
Genetic and Environmental Interaction in Type 1 Diabetes: a Relationship Between Genetic Risk Alleles and Molecular Traits of Enterovirus Infection?
Blanter M; Sork H; Tuomela S; Flodstrom-Tullberg M
Letter: DIABETOLOGIA. 2019;62(6):1100-1103
Large enteroviral vaccination studies to prevent type 1 diabetes should be well founded and rely on scientific evidence. Reply to Skog O, Klingel K, Roivainen M et al [letter]
Dunne JL; Richardson SJ; Atkinson MA; Craig ME; Dahl-Jorgensen K; Flodstroem-Tullberg M; Hyoety H; Lloyd RE; Morgan NG; Pugliese A
Review: REVIEWS IN MEDICAL VIROLOGY. 2016;26(4):251-267
Enteroviral proteases: structure, host interactions and pathogenicity
Laitinen OH; Svedin E; Kapell S; Nurminen A; Hytonen VP; Flodstrom-Tullberg M
Conference publication: IMMUNOLOGY. 2014;143:27
Interactions between intestinal epithelial cells and Coxsackievirus B and the role of the Type III Interferons
Stone VM; Larsson P; Domsgen E; Holmlund U; Ekstrom ES; Flodstrom-Tullberg M
Conference publication: PEDIATRIC PULMONOLOGY. 2014;49:415
CHANGED ENTEROHEPATIC PROCESSING OF CHOLINE IN SMALL INTESTINE OF CYSTIC FIBROSIS MICE
Hjelte L; Svedin E; Cheng Y; Duan R; Flodstrom-Tullberg M; Nilsson AKE
Letter: DIABETOLOGIA. 2014;57(3):647-649
Detection of enterovirus in the islet cells of patients with type 1 diabetes: what do we learn from immunohistochemistry? Reply to Hansson SF, Korsgren S, Ponten F et al [letter]
Richardson SJ; Leete P; Dhayal S; Russell MA; Oikarinen M; Laiho JE; Svedin E; Lind K; Rosenling T; Chapman N; Bone AJ; Foulis AK; Frisk G; Flodstrom-Tullberg M; Hober D; Hyoty H; Pugliese A; Morgan NG
Book chapter: HANDBOOK OF VITAMIN D IN HUMAN HEALTH. 2013;p. 254-274
Vitamin D and cystic fibrosis
Pincikova T; Flodström-Tullberg M
Conference publication: DIABETOLOGIA. 2012;55:S198
IFN-lambda elicits an antiviral state and protects human islets from coxsackievirus infection
Flodstrom-Tullberg M; Lind K
Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2012;76(2):209
Increased Susceptibility to an Enterovirus Infection in a Mouse Model for Cystic Fibrosis
Svedin E; Huhn MH; Lind K; Larsson P; Flodstrom-Tullberg M
Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2012;76(2):195
Previous Maternal Infection Protects Genetically Susceptible Offspring from Virus-Induced Type 1 Diabetes
Larsson P; Lakshmikanth T; Svedin E; Flodstrom-Tullberg M
Review: CLINICAL AND EXPERIMENTAL IMMUNOLOGY. 2012;168(1):30-38
Immunology in the clinic review series; focus on type 1 diabetes and viruses: the innate immune response to enteroviruses and its possible role in regulating type 1 diabetes
Lind K; Huehn MH; Flodstrom-Tullberg M
Conference publication: JOURNAL OF MEDICAL VIROLOGY. 2011;83(9):1674
IFIH1/MDA5 in the Innate Immune Response to Coxsackievirus Infection
Flodstrom-Tullberg M
Conference publication: DIABETOLOGIA. 2010;53:S176
Depletion of IL-2/15 receptor beta-positive cells protects from diabetes in non-obese diabetic mice: role of natural killer cells and a subset of CD8+T cells
Brauner H; Johansson S; Hall H; Flodstrom-Tullberg M; Karre K; Hoglund P
Conference publication: DIABETOLOGIA. 2010;53:S225
Active CFTR channels are important for insulin- and glucagon secretion
Edlund A; Huhn M; Flodstrom-Tullberg M; Eliasson L
Conference publication: DIABETOLOGIA. 2010;53:S186-S187
Coxsackievirus B3 induces the mRNA expression of IFNbeta and viral recognition receptors in human pancreatic islets
Lind K; Larsson PG; Huhn M; Korsgren O; Flodstrom-Tullberg M
Conference publication: DIABETOLOGIA. 2010;53:S174
Previous Coxsackievirus B3 infection in mothers protect offspring from virus-induced type 1 diabetes
Larsson PG; Flodstrom-Tullberg M
Review: CURRENT OPINION IN IMMUNOLOGY. 2009;21(6):634-640
Natural killer cells in human autoimmunity
Flodstrom-Tullberg M; Bryceson YT; Shi F-D; Hoglund P; Ljunggren H-G
Conference publication: DIABETOLOGIA. 2009;52:S194
Distinct phenotype and function of natural killer cells in the pancreas of non obese diabetic mice
Brauner H; Elemans M; Lemos S; Broberger C; Holmberg D; Flodstrom-Tullberg M; Karre K; Hoglund P
Published conference paper: ANNALS OF THE NEW YORK ACADEMY OF SCIENCES. 2008;1150:213-216
Co-transplantation of Stromal Cells Interferes with the Rejection of Allogeneic Islet Grafts
Jacobson S; Kumagai-Braesch M; Tibell A; Svensson M; Flodstroem-Tullberg M
Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2008;68(2):201
The human pancreatic islet response to coxsackievirus infection
Lind K; Huhn M; Hultcrantz M; Flodstrom-Tullberg M
Conference publication: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2008;68(2):222-223
Co-transplantation of stromal cells interferes with the rejection of allogeneic islet grafts
Jacobson S; Kumagai-Braesch M; Tibell A; Svensson M; Flodstrom-Tullberg M
Review: FRONTIERS IN BIOSCIENCE - LANDMARK. 2008;13:4838-4851
Recent acquisitions on the genetic basis of autoimmune disease
Hill NJ; King C; Flodstrom-Tullberg M
Conference publication: ACTA DIABETOLOGICA. 2007;44:S23
Alpha production dominates the early human natural killer cell response to coxsackievirus infection
Huhn MH; Hultcrantz M; Lind K; Ljunggren H-G; Malmberg K-J; Flodstrom-Tullberg M
Conference publication: ACTA DIABETOLOGICA. 2007;44:S24
The beta cell response to cytokines governs CD8+ T-cell insulitis
Hultcrantz M; Jacobson S; Sarvetnick N; Flodstrom-Tullberg M
Conference publication: DIABETOLOGIA. 2007;50:S190
NK cells in type 1 diabetes
Branner H; Wareing M; Flodstrom-Tullberg M; Karre K; Hoglund P
Review: EUROPEAN JOURNAL OF IMMUNOLOGY. 2007;37(3):589-597
The target tissue in autoimmunity--an influential niche.
Hill NJ; Hultcrantz M; Sarvetnick N; Flodström-Tullberg M
Published conference paper: TRANSPLANTATION. 2005;79(9):1104-1109
Differences in suppressor of cytokine signaling-I (SOCS-1) expressing islet allograft destruction in normal BALB/c and spontaneously-diabetic NOD recipient mice
Solomon M; Flodström-Tullberg M; Sarvetnick N
Conference publication: FASEB JOURNAL. 2005;19(5):A1438
Suppressor of cytokine signaling-1 (SOCS-1) renders islets apoptosis resistant and enhances their survival during alloimmune attack
Solomon MF; Flodstrom-Tullberg M; Sarvetnick N
Review: MICROBES AND INFECTION. 2003;5(10):911-921
Viral infections:: their elusive role in regulating susceptibility to autoimmune disease
Flodström-Tullberg M
Review: SCANDINAVIAN JOURNAL OF IMMUNOLOGY. 2002;55(5):432-441
The natural killer cell -: Friend or foe in autoimmune disease?
Flodström M; Shi FD; Sarvetnick N; Ljunggren HG
Review: UPSALA JOURNAL OF MEDICAL SCIENCES. 2000;105(2):17-34
Novel experimental strategies to prevent the development of type 1 diabetes mellitus
Sandler S; Andersson AK; Barbu A; Hellerström C; Holstad M; Karlsson E; Sandberg JO; Strandell E; Saldeen J; Sternesjö J; Tillmar L; Eizirik DL; Flodström M; Welsh N
Review: DIABETOLOGIA. 1996;39(8):875-890
The harmony of the spheres: Inducible nitric oxide synthase and related genes in pancreatic beta cells
Eizirik DL; Flodstrom M; Karlsen AE; Welsh N
Visa fler

Om mig

Forskningsbeskrivning

Artiklar

Alla övriga publikationer

Anställningar

Examina och utbildning

Nyheter från KI

Kalenderhändelser från KI